SudhakerDhanwadaRaoMD
Endocrinology • Detroit, MIOsteoporosis & Bone Metabolism Medicine, Parathyroid, Clinical Pharmacology
Section Head, Bone & Mineral Disorders and Director, Bone & Mineral Research Laboratory, Henry Ford Health System, Detroit, MI
Dr. Rao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3031 W Grand Blvd
Ste 800
Detroit, MI 48202Phone+1 313-916-3605Fax+1 313-916-8343
Summary
- Dr. Sudhaker D. Rao is an endocrinologist in Detroit, MI and is affiliated with Henry Ford Hospital and Henry Ford West Bloomfield Hospital. He received his medical degree from Gandhi Medical College and has been in practice 48 years. He specializes in the broad area of bone & mineral disorders with special research interest in the role of vitamin D nutrition on bone mineralization and parathyroid tumorigenesis. He has published extensively in the field (>300 peer reviewed publications) and was the first to report on the atypical femur fractures after long term bisphosphonate therapy. Also, the first to conduct a randomized clinical trial of surgery Vs. no surgery in mild asymptomatic primary hyperparathyroidism.
Education & Training
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1975 - 1977- Henry Ford Health/Henry Ford HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1977
New York-Presbyterian/QueensResidency, Internal Medicine, 1973 - 1974- New York-Presbyterian/QueensInternship, Transitional Year, 1972 - 1973
Gandhi Medical CollegeClass of 1969
Certifications & Licensure
MI State Medical License 1974 - 2026- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic Primary Hyperparathyroidism Start of enrollment: 1997 Apr 01
- Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 260 citationsDevelopment of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment ...Ping Gao, Stephen Scheibel, Pierre D’Amour, Markus R. John, Sudhaker D Rao
Journal of Bone and Mineral Research. 2001-04-01 - 20 citationsVitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline.Marie B Demay, Anastassios G Pittas, Daniel D Bikle, Dima L Diab, Mairead E Kiely
The Journal of Clinical Endocrinology and Metabolism. 2024-07-12 - 277 citationsPrimary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.Aliya Khan, David A. Hanley, René Rizzoli, Jens Bollerslev, J. E. M. Young
Osteoporosis International. 2017-01-01
Journal Articles
- Fibrogenesis Imperfecta Ossium: Clinical Approach to Diagnosis and Management of a Rare Skeletal DisorderSudhaker D Rao, Ruban Dhaliwal, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
‘Around 30% over Diagnosed for Osteoporosis, Need No Treatment’February 4th, 2021
Vit D Supplements Flop Again for Bone HealthSeptember 24th, 2019- Case Report: Hajdu-Cheney SyndromeOctober 12th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
